AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12107508
Drug: Ophthalmic timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ophthalmic timolol
Trial: 3898795
Drug: Intravenous timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous timolol
Trial: 7697521
Drug: Francisella tularensis
RxNorm normalized name: Francisella tularensis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Francisella tularensis live vaccine strain (LVS)
Trial: 2653095
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl (100 micrograms in saline 10 ml)
Trial: 25778541
Drug: Grape/blueberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grape/blueberry juice (841 mg ACN/litre)
Trial: 25778541
Drug: Grape/blueberry smoothie
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grape/blueberry smoothie (983 mg ACN/litre)
Trial: 25778541
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro absorption of grape/blueberry extract
Trial: 24337060
Drug: Online version
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Online version of the FSFI (G-pp/ol after 15 days)
Trial: 24337060
Drug: Traditional pen
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional pen and paper version of the FSFI (G-ol/pp after 15 days)
Trial: 18753292
Drug: Terlipressin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (2 mg infusion)
Trial: 10917403
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg FLX daily
Trial: 10917403
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg FLX weekly
Trial: 1626677
Drug: Low-dose morphine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose morphine combined with bupivacaine for intercostal nerve blocks
Trial: 15236812
Drug: Disulfiram treatment
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disulfiram treatment
Trial: 31793645
Drug: Syrup (alternative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup (alternative supplement for children)
Trial: 31793645
Drug: Any supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any supplement (general outcome)
Trial: 22609816
Drug: Sertindole (modal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertindole (modal dose 16 mg/day)
Trial: 8083103
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment (control group)
Trial: 2287773
Drug: Once-a-day amikacin
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Once-a-day amikacin (14 mg/kg per day)
Trial: 2287773
Drug: Once-a-day netilmicin
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Once-a-day netilmicin (6.6 mg/kg per day)
Trial: 6795047
Drug: 1,25-dihydroxycholecalciferol (1,25(OH)2D3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-dihydroxycholecalciferol (1,25(OH)2D3) alone in a daily dose of 0.25 micrograms
Trial: 29893798
Drug: Fidaxomicin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fidaxomicin (200 mg once daily)
Trial: 28487415
Drug: Standard therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapeutic pharmaceutical protocols (Control)
Trial: 26377909
Drug: 40% dextrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40% dextrose gel (200 mg/kg)
Trial: 23587733
Drug: teduglutide (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teduglutide (0.05 mg/kg/day s.c.)
Trial: 21863254
Drug: First eye
RxNorm normalized name: Medi-First Eyewash 98.3% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First eye surgery under topical anesthesia
Trial: 21863254
Drug: Second eye
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second eye surgery under topical anesthesia
Trial: 24067390
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive pill (OCP) users
Trial: 7959185
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg atenolol (a selective beta 1 antagonist)
Trial: 7959185
Drug: Matched dummy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched dummy tablets (control)
Trial: 21741230
Drug: Lactobacillus brevis
RxNorm normalized name: Lactobacillus brevis
DrugBank: Lactobacillus brevis (DB18532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus brevis CD2 lozenges
Trial: 23644602
Drug: No L.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No L. brevis lozenge (control)
Trial: 23529727
Drug: GSK1322322 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1322322 with H2 blocker
Trial: 19923796
Drug: GLY-230 (250,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLY-230 (250, 500, or 750 mg daily for 14 days)
Trial: 23242004
Drug: Rifampicin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (600 mg once daily for 5 days)
Trial: 8199751
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg pantoprazole
Trial: 10235417
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg pantoprazole
Trial: 8199751
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg pantoprazole
Trial: 7977327
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg orally)
Trial: 21245882
Drug: Calcium fortified
RxNorm normalized name: Calcium fortified whole milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium fortified laddoo containing 405 mg calcium per day and a monthly vitamin D supplement of 30,000 IU
Trial: 21245882
Drug: Non-fortified laddoo
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fortified laddoo containing 156 mg of indigenous calcium and a monthly vitamin D supplement of 30,000 IU
Trial: 16409195
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite immunotherapy with Alutard SQ (Dermatophagoides pteronyssinus extract) for 52 weeks
Trial: 12627930
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 80 mg administered after consumption of a standardized continental breakfast
Trial: 12627930
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 80 mg administered during a fasting period
Trial: 28198032
Drug: Metoclopramide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (0.5 mg/kg, IV, three times a day)
Trial: 28198032
Drug: Ondansetron (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (0.5 mg/kg, IV, three times a day)
Trial: 23778412
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg daily
Trial: 10229295
Drug: Hydrene (triamterene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrene (triamterene 50 mg with hydrochlorothiazide 25 mg) daily
Trial: 1878335
Drug: Nicardipine 40
RxNorm normalized name: niCARdipine 40 mg/200 mL-D5% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 40 mg slow-release b.i.d.
Trial: 1878335
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg slow-release b.i.d.
Trial: 6130842
Drug: Quazepam 15
RxNorm normalized name: quazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quazepam 15 mg/night
Trial: 27545509
Drug: Omega 3/6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega 3/6 capsules (three capsules twice daily)
Trial: 27533157
Drug: Abaloparatide, 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abaloparatide, 80 μg
Trial: 19452124
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg per day)
Trial: 17465977
Drug: Alfentanil 0.5
RxNorm normalized name: alfentanil 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 0.5 mg intravenously
Trial: 15143082
Drug: VAC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC therapy (vincristine, dactinomycin, and cyclophosphamide)
Trial: 15143082
Drug: VAC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC therapy with concomitant abdominal radiotherapy
Trial: 11166149
Drug: Psychological Distress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological Distress Inventory and Hospital Anxiety and Depression Scale administered before and during chemotherapy, and at the first follow‐up visit.
Trial: 30181172
Drug: Adjuvant combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant combination chemotherapy
Trial: 3349432
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tumor burden, histologic subtype, and sex
Trial: 6439019
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (NTG‐TTS), 5 mg/24 hr
Trial: 31244356
Drug: Methotrexate +
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate + IFX therapy
Trial: 28088187
Drug: Oral ergocalciferol
RxNorm normalized name: Ergocalciferol
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ergocalciferol plus calcitriol (n = 32)
Trial: 28088187
Drug: Oral ergocalciferol
RxNorm normalized name: Ergocalciferol
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ergocalciferol plus placebo (n = 36)
Trial: 21102493
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac (60 mg) before surgery
Trial: 19579920
Drug: 200 mcg
RxNorm normalized name: CrM 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg misoprostol placed in posterior fornix of case group
Trial: 19579920
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet in control group
Trial: 9924327
Drug: Dorzolamide/timolol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide/timolol combination solution administered twice daily (Cosopt)
Trial: 9924327
Drug: Dorzolamide solution
RxNorm normalized name: dorzolamide Ophthalmic Solution
DrugBank: Dorzolamide (DB00869)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dorzolamide solution twice daily plus timolol maleate solution twice daily (concomitant)
Trial: 9924327
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (combination and concomitant)
Trial: 23462886
Drug: MSDC-0160 (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSDC-0160 (higher doses)
Trial: 15963388
Drug: pioglitazone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone (45 mg)
Trial: 21672053
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose CYT003-QbG10
Trial: 17458083
Drug: Corsodyl gel
RxNorm normalized name: chlorhexidine gluconate Oral Gel [Corsodyl]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corsodyl gel + surgical dressing
Trial: 17458083
Drug: Corsodyl gel
RxNorm normalized name: chlorhexidine gluconate Oral Gel [Corsodyl]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corsodyl gel
Trial: 12776809
Drug: SB-LOT (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-LOT (30 mg coumarin and 180 mg troxerutin t.i.d.)
Trial: 19637354
Drug: Dual-screen (annual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-screen (annual chest X-ray and 4-monthly sputum cytology)
Trial: 12960598
Drug: Incremental nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incremental nitroglycerin infusion (NTG+Inf)
Trial: 7567309
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (25 mg/kg/day in 3 divided doses for 10 days)
Trial: 7567309
Drug: Ceftibuten (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (9 mg/kg once daily for 10 days)
Trial: 2174492
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of delta-9-tetrahydrocannabinol (THC) followed by 6.4 mg flumazenil
Trial: 30773300
Drug: Decaffeinated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated group (150 mL decaffeinated coffee)
Trial: 30773300
Drug: Caffeinated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated group with CYP1A2 rs762551 CC genotype and daily caffeine consumption ≤90 mg/day
Trial: 30773300
Drug: Caffeinated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated group with CYP1A2 rs762551 AA/CA genotype and daily caffeine consumption ≤90 mg/day
Trial: 20694295
Drug: Agaricus sylvaticus
RxNorm normalized name: AGARICUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agaricus sylvaticus (30 mg/kg/day)
Trial: 16607096
Drug: Late initiation
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Late initiation of hormone therapy (HT)
Trial: 16607096
Drug: Late initiation
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Late initiation of hormone therapy (HT) in women aged 60-69 years
Trial: 10801247
Drug: Tangeretin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tangeretin (50 micromol/L)
Trial: 10801247
Drug: Tangerine juice
RxNorm normalized name: TANGERINE JUICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tangerine juice (200 mL)
Trial: 8664811
Drug: Treatment 1
RxNorm normalized name: CVS Acne Treatment 10% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment 1 (250 mg of standard vitamin C, 200 mg of vitamin E and 6 mg of beta‐carotene three times a day)
Trial: 8664811
Drug: Treatment 2
RxNorm normalized name: epoch Blemish Treatment 2 % Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment 2 (150 mg of standard vitamin C, 500 mg of slow release vitamin C, 75 mg of vitamin E and 15 mg of beta‐carotene once a day)
Trial: 15887427
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg HPV 16 L1 VLP vaccine
Trial: 15887427
Drug: 20 microg
RxNorm normalized name: Calcifediol 20 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 microg HPV 16 L1 VLP vaccine
Trial: 15887427
Drug: 40 microg
RxNorm normalized name: Travoprost 40 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 microg HPV 16 L1 VLP vaccine
Trial: 15887427
Drug: 80 microg
RxNorm normalized name: Folic acid 80 microgram/mL oral solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 microg HPV 16 L1 VLP vaccine
Trial: 2853497
Drug: Intensified non‐medicamentous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified non‐medicamentous basic therapy (fat‐modified diet and endurance training)
Trial: 2853497
Drug: Clofibric acid
RxNorm normalized name: Clofibrate
DrugBank: Clofibrate (DB00636)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clofibric acid (1.6 g)
Trial: 29276166
Drug: Accelerated oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Accelerated oxytocin titration (AOT) - initial dose 4 mU/min with increments of 4 mU/min
Trial: 29276166
Drug: Standard gradual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard gradual oxytocin titration (GOT) - initial dose 2 mU/min with increments of 2 mU/min
Trial: 20801085
Drug: Ciclosporin A
RxNorm normalized name: Ciclosporin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclosporin A (3.5-4.0 mg/kg per day)
Trial: 20801085
Drug: Ciclosporin A
RxNorm normalized name: Ciclosporin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclosporin A with intermittent prednisone (0.75 mg/kg, alternating 10 days on with 10 days off)
Trial: 10507567
Drug: Topical brimonidine
RxNorm normalized name: brimonidine Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical brimonidine tartrate 0.2%
Trial: 1902417
Drug: Mitomycin or
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin or Adriamycin administered endovesically
Trial: 28433498
Drug: Aripiprazole once-monthly
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole once-monthly 400mg (AOM 400)
Trial: 22509905
Drug: 500 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 μg nebulized ipratropium bromide
Trial: 6132936
Drug: Bromazepam (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (18 mg/day)
Trial: 6132936
Drug: Diazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (15 mg/day)
Trial: 23110368
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg NGX426
Trial: 23110368
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg NGX426
Trial: 15778883
Drug: 0.62 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.62 g/kg alcohol (A)
Trial: 15778883
Drug: Declining BACs
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Declining BACs (73 mg/100 ml)
Trial: 15778883
Drug: Declining BACs
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Declining BACs (64 mg/100 ml)
Trial: 7537116
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) 480 micrograms subcutaneously
Trial: 7324741
Drug: Epidural anaesthesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural anaesthesia with 0.5% bupivacaine and epinephrine (5 micrograms/ml)
Trial: 31199090
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg voxelotor
Trial: 31199090
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg voxelotor
Trial: 28202260
Drug: Both drugs
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both drugs (Group A/B)
Trial: 11143776
Drug: ACE inhibitor,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor, ramipril
Trial: 9292644
Drug: PGE2+oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE2+oxytocin infusion
Trial: 3800032
Drug: Propranolol, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 40 mg orally every 6 h, beginning 24 h prior to bupivacaine administration
Trial: 18258368
Drug: Gabapentin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (up to 2400 mg/day)
Trial: 14649343
Drug: Intrathecal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal midazolam (2 mg) added to hyperbaric bupivacaine (15 mg) and buprenorphine (0.15 mg)
Trial: 14649343
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine (15 mg) plus buprenorphine (0.15 mg)
Trial: 10992829
Drug: Local morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local morphine (2 mg)
Trial: 10992829
Drug: Systemic morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic morphine (2 mg)
Trial: 1399498
Drug: Nisoldipine 5
RxNorm normalized name: nisoldipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 5 mg twice a day for 2 weeks
Trial: 27250349
Drug: Experimental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatment 1
Trial: 18924053
Drug: Telephone intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telephone intervention (weekly phone calls discussing physical activity)
Trial: 27268572
Drug: Weekly writing
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly writing practice alone
Trial: 28929131
Drug: Dopamine agonist
RxNorm normalized name: Dopamine agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine agonist bromocriptine